Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease

Immunity

Volumn 5, Issue 3, 1996, Pages 253-262

  Pewe, Lecia ^a   Wu, Gregory F ^b   Barnett, Edward M ^b   Castro, Raymond F ^b   Perlman, Stanley ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DEMYELINATION; ENCEPHALOMYELITIS; MOUSE; MURINE HEPATITIS CORONAVIRUS; MUTATION; NONHUMAN; PRIORITY JOURNAL; RNA SEQUENCE; VIRUS REPLICATION;

EID: 0030249395     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80320-9     Document Type: Article

References (61)

1. Adami, C., Pooley, J., Glomb, J., Stecker, E., Fazal, F., Fleming, J.O., and Baker, S.C. (1995). Evolution of mouse hepatitis virus (MHV) during chronic infection: quasispecies nature of the persisting MHV RNA. Virology 209, 337-346.
2. Armstrong, J., Niemann, H., Smeekens, S., Rottier, P., and Warren, G. (1984). Sequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a coronavirus. Nature 308, 751-752.
3. Banner, L., Keck, J.G., and Lai, M.M.C. (1990). A clustering of RNA recombination sites adjacent to a hypervariable region of the peplomer gene of murine coronavirus. Virology 175, 548-555.
4. d-restricted cytotoxic T-lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein. J. Virol. 67, 7041-7049.
5. b-restricted CTL response. J. Gen. Virol. 77, 315-325.
6. Bertoletti, A., Costanzo, A., Chisari, f.V., Levero, M., Artini, M., Sette, A., Penna, A., Giuberti, T., Fiaccadori, F., and Ferrari, C. (1994a). Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J. Exp. Med. 180, 933-943.
7. Bertoletti, A., Sette, A., Chisari, F.V., Penna, A., Levrero, M., De Carli, M., Fiaccadori, F., and Ferrari, C. (1994b). Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369, 407-410.
8. Buchmeier, M.J., Lewicki, H.A., Talbot, P.J., and Knobler, R.L. (1984). Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 132, 261-270.
9. Casanova, J.-L., and Maryanski, J. (1993). Antigen-selected T-cell receptor diversity and self-nonself homology. Immunol. Today 14, 391-394.
10. Castro, R.F., and Perlman, S. (1995). CD8+ T cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J. Virol. 69, 8127-8131.
11. Castro, R.F., Evans, G.D., Jaszewski, A., and Perlman, S. (1994). Coronavirus-induced demyelination occurs in the presence of virus-specific cytotoxic T cells. Virology 200, 733-743.
12. Couillin, I., Culmann-Penciolelli, B., Gomard, E., Choppin, J., Levy, J.-P., Guillet, J.-G., and Saragosti, S. (1994). Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 nef protein. J. Exp. Med. 180, 1129-1134.
13. Dalziel, R.G., Lampert, P.W., Talbot, P.J., and Buchmeier, M.J. (1986). Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J. Virol. 59, 463-471.
14. Eisenlohr, L.C., Yewdell, J.W., and Bennink, J.R. (1992). Flanking sequence influences the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175, 481-487.
15. Falk, K., Rötzschke, O., Stevanovic, S., Jung, G., and Rammensee, H.-G. (1991). Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351, 290-296.
16. Fleming, J.O., Shubin, R.A., Sussman, M.A., Casteel, N., and Stohlman, S.A. (1989). Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 168, 162-167.
17. Franco, A., Ferrari, C., Sette, A., and Chisari, F.V. (1995). Viral mutations, TCR antagonism and escape from the immune response. Curr. Opin. Immunol. 7, 524-531.
18. Gairin, J., and Oldstone, M. (1992). Design of high-affinity MHC-specific antagonist peptides that inhibit cytotoxic T-lymphocyte activity: implications for control of viral disease. J. Virol. 66, 6755-6762.
19. b MHC complex class I molecules and presented to cytotoxic T lymphocytes. J. Virol. 69, 2297-2305.
20. Gombold, J., Sutherland, R., Lavi, E., Paterson, Y., and Weiss, S.R. (1995). Mouse hepatitis virus A59-induced demyelination can occur in the absence of CD8+ T cells. Microb. Pathog. 18, 211-221.
21. Haspel, M.V., Lampert, P.W., and Oldstone, M.B.A. (1978). Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. Proc. Natl. Acad. Sci. USA 75, 4033-4036.
22. Hingorani, R., Monteiro, J., Furce, R., Chartash, E., Navarette, G., Pergolizzi, R., and Gregersen, P.K. (1996). Oligoclonality of Vβ3 TCR chains in the CD8+ T cell population of rheumatoid arthritis patients. J. Immunol. 156, 852-856.
23. Jacobsen, G., and Perlman, S. (1990). Localization of virus and antibody response in mice infected persistently with MHV-JHM. Adv. Exp. Med. Biol. 276, 573-578.
24. b-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur. J. Immunol. 22, 2663-2667.
25. Kalams, S., Johnson, R., Trocha, A., Dynan, M., Ngo, H., D'Aquila, R., Kurnick, J., and Walker, B. (1994). Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179, 1261-1271.
26. Klenerman, P., Rowland-Jones, S., McAdam, S., Edwards, J., Daenke, S., Lalloo, D., Koppe, B., Rosenberg, W., Boyd, D., Edwards, A., Glangrande, P., Phillips, R.E., and McMichael, A.J. (1994). Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 gag variants. Nature 369, 403-407.
27. Knobler, R.L., Lambert, P.W., and Oldstone, M.B.A. (1982). Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4. Nature 298, 279-280.
28. Körner, H., Schliephake, A., Winter, J., Zimprich, F., Lassmann, H., Sedgwick, J., Siddell, S., and Wege, H. (1991). Nucleocapsid or spike protein-specific CD4+ T lymphocytes protect against coronavirus-induced encephalomyelitis in the absence of CD8+ T cells. J. Immunol. 147, 2317-2323.
29. Kyuwa, S., and Stohlman, S.A. (1990). Pathogenesis of a neurotropic murine coronavirus, strain JHM in the central nervous system of mice. Semin. Virol. 1, 273-280.
30. Lavi, E., Gilden, D., Wroblewska, Z., Rorke, L., and Weiss, S. (1984). Experimental demyelination produced by the A59 strain of MHV. Neurology 34, 597-603.
31. Lewicki, H., Von Herrath, M., Evans, C., Whitton, J.L., and Oldstone, M. (1995). CTL escape viral variants. II. Biologic activity in vivo. Virology 211, 443-450.
32. Ljunggren, H.G., Stam, N.J., Olhen, C., Neefjes, J.J., Hoglund, P., Heemels, M.T., Bastin, J., Schumacher, T.N., Townsend, A., and Karre, K. (1990). Empty MHC class I molecules come out in the cold. Nature 346, 476-480.
33. Maryanski, J., Jongeneel, C., Bucher, P., Casanova, J.-L., and Walker, P. (1996). Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones. Immunity 4, 47-55.
34. Meyerhans, A., Cheynier, R., Albert, J., Seth, M., Kwok, S., Sninsky, J., Morfeldt-Manson, L.A.B., and Wain-Hobson, S. (1989). Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58, 901-910.
35. Miedema, F., and Klein, M.R. (1996). AIDS pathogenesis: a finite immune response to blame? Science 272, 505-506.
36. Morris, V., Tieszer, C., Mackinnon, J., and Percy, D. (1989). Characterization of coronavirus JHM variants isolated from Wistar Furth rats with a viral-induced demyelinating disease. Virology 169, 127-136.
37. Moskophidis, D., and Zinkernagel, R.M. (1995). Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus. J. Virol. 69, 2187-2193.
38. Nowak, M.A., and Bangham, C.R.M. (1996). Population dynamics of immune responses to persistent viruses. Science 272, 74-79.
39. Pantaleo, G., Demarest, J., Soudeyns, H., Graziosi, C., Denis, F., Adelsberger, J., Borrow, P., Saag, M., Shaw, G., Sekaly, R., and Fauci, A. (1994). Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 370, 463-467.
40. Parker, S.E., Gallagher, T.M., and Buchmeier, M.J. (1989). Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology 173, 664-673.
41. Pearce, B.D., Hobbs, M.V., McGraw, T.S., and Buchmeier, M.J. (1994). Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo. J. Virol. 68, 5483-5495.
42. Perlman, S., Schelper, R., Bolger, E., and Ries, D. (1987). Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody. Microb. Pathog. 2, 185-194.
43. Perlman, S., Jacobsen, G., Olson, A.L., and Afifi, A. (1990). Identification of the spinal cord as a major site of persistence during chronic infection with a murine coronavirus. Virology 175, 418-426.
44. Phillips, R.E., Rowland-Jones, S., Nixon, D.F., Gotch, F.M., Edwards, J.P., Ogunlesi, A.O., Elvin, J.G., Rothbard, J.A., Bangham, C.R.M., Rizza, C.R., and McMichael, A.J. (1991). Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453-459.
45. Pircher, H., Moskophidis, D., Rohrer, U., Burki, K., Hengartner, H., and Zinkernagel, R. (1990). Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346, 629-633.
46. Rehermann, B., Pasquinelli, C., Mosier, S., and Chisari, F. (1995). Hepatitis B virus (HBV) sequence variation in cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. J. Clin. Invest. 96, 1527-1534.
47. Sanger, F., Nicklen, S., and Coulson, A.R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
48. Schumacher, T.N.M., Heemels, M.-T., Neefjes, J.J., Kast, W.M., Melief, C.J.M., and Ploegh, H.L. (1990). Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 62, 563-567.
49. Sorensen, O., Perry, D., and Dales, S. (1980). In vivo and in vitro models of demyelinating diseases. III. JHM virus infection of rats. Arch. Neurol. 37, 478-484.
50. Stohlman, S.A., Matsushima, G.K., Casteel, N., and Weiner, L.P. (1986). In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication. J. Immunol. 136, 3052-3056.
51. Stohlman, S.A., Bergmann, C.C., van der Veen, R.C., and Hinton, D.R. (1995). Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J. Virol. 69, 684-694.
52. Sun, N., and Perlman, S. (1995). Spread of a neurotropic coronavirus to spinal cord white matter via neurons and astrocytes. J. Virol. 69, 633-641.
53. Watanabe, R., Wege, H., and ter Meulen, V. (1987). Comparative analysis of coronavirus JHM-induced demyelinating encephalomyelitis in Lewis and Brown Norway rats. Lab. Invest. 57, 375-384.
54. Wege, H. (1995). Immunopathological aspects of coronavirus infection. Springer Semin. Immunopathol. 17, 133-148.
55. Williamson, J.S., and Stohlman, S.A. (1990). Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J. Virol. 64, 4589-4592.
56. Williamson, J.S., Sykes, K.C., and Stohlman, S.A. (1991). Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J. Neuroimmunol. 32, 199-207.
57. Wolinsky, S.M., Korber, B., Neumann, A.U., Daniels, M., Kunstman, K., Whetsell, A., Furtado, M., Cao, Y., Ho, D., Safrit, J., and Koup, R. (1996). Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272, 537-542.
58. Xue, S., Jaszewski, A., and Perlman, S. (1995). Identification of a CD4+ T cell epitope within the M protein of a neurotropic coronavirus. Virology 208, 173-179.
59. Yamaguchi, K., Goto, N., Kyuwa, S., Hayami, M., and Toyoda, Y. (1991). Protection of mice from a lethal coronavirus infection in the central nervous system by adoptive transfer of virus-specific T cell clones. J. Neuroimmunol. 32, 1-9.
60. b at 2.4 Å resolution: implications for antigen-determinant selection. Cell 76, 39-50.
61. Zinkernagel, R.M. (1996). Immunology taught by viruses. Science 277, 173-178.